Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-2023PMID 19244128PMCID PMC3198868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

  2008cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Effects of recombinant erythropoietin on breast cancer-initiating cells.

  2007cited by this paper
• [Isolation and identification of tumor stem-like cells from human glioma cell line U87 after treatment of vincristine].

  2007cited by this paper
• The continuum of care: a paradigm for the management of metastatic colorectal cancer.

  2007cited by this paper
• Targeting of Insulin-like Growth Factor-I Receptor with a Monoclonal Antibody Inhibits Growth of Hepatic Metastases from Human Colon Carcinoma in Mice

  2007cited by this paper
• Targeting hedgehog in cancer stem cells: how a paradigm shift can improve treatment response.

  2007cited by this paper
• Cancer stem cell: target for anti‐cancer therapy

  2007cited by this paper
• Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

  2006cited by this paper
• Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

  2006cited by this paper
• Invasive growth: a MET-driven genetic programme for cancer and stem cells

  2006cited by this paper
• Capecitabine: a review.

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway

  2004cited by this paper
• An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.

  2003cited by this paper
• Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.

  2002cited by this paper
• Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway.

  2001cited by this paper
• Cancer statistics

  1989cited by this paper

• Anti-tumor Effects of CD133-Targeted CAR-NK92MI Cells in Colorectal Cancer

  2026cites this paper
• Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil

  2025cites this paper
• Therapeutic potential of stem cells in colorectal cancer management: Current trends and future prospects

  2025cites this paper
• miR-340 reverses chemotherapy resistance in colon cancer via the PDCD4/WNT/β-catenin signalling pathway

  2025cites this paper
• A Novel Erinacine S Derivative from Hericium erinaceus Overcomes Chemoresistance in Colorectal Cancer Cells by Enhancing TRAIL/TNFR1/DR5 Expression through Histone Acetylation

  2025influential citation
• Oncogenic Role of EEPD1 Via Protein Kinase B Phosphorylation in Colorectal Cancer.

  2025cites this paper
• Human equilibrative nucleoside transporter 1 and concentrative nucleoside transporter 1 in colorectal cancer: What do we know? A systematic review.

  2025cites this paper
• The prognostic importance of the negative regulators of ferroptosis, GPX4 and HSPB1, in patients with colorectal cancer

  2025cites this paper
• ITGA4 Contributes to 5-Fluorouracil Resistance by Up-Regulating PI3K/AKT Signaling: Evidence from Network Pharmacology, Molecular Docking and Experimental Verification

  2025cites this paper
• Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology

  2025cites this paper
• Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions

  2025cites this paper
• Strategies for overcoming ABC transporter mediated drug resistance in colorectal cancer.

  2025cites this paper
• The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study

  2025cites this paper
• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells

  2025cites this paper
• B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancer.

  2025cites this paper
• SOX17: a new therapeutic target for immune evasion of colorectal cancer

  2025cites this paper
• Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance

  2024cites this paper
• High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data

  2024cites this paper
• Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles

  2024cites this paper
• Brexpiprazole Prevents the Malignant Progression of Human Colorectal Cancer Cells and Increases Its Sensitivity to EGFR Inhibition.

  2024cites this paper
• A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer

  2024cites this paper
• Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer

  2024cites this paper
• Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC

  2024cites this paper
• Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing

  2024cites this paper
• STAT3 mediates cancer stem‐like tumorsphere formation and PD‐L1 expression to contribute radioresistance in HBV‐positive hepatocellular carcinoma

  2024cites this paper
• Tumour response following preoperative chemotherapy is affected by body mass index in patients with colorectal liver metastases

  2024cites this paper
• Docosahexaenoic acid inhibits the invasion and migration of colorectal cancer by reversing EMT through the TGF-β1/Smad signaling pathway.

  2024cites this paper
• Specific SOX10 enhancer elements modulate phenotype plasticity and drug resistance in melanoma

  2024cites this paper
• IGF-1-mediated FOXC1 overexpression induces stem-like properties through upregulating CBX7 and IGF-1R in esophageal squamous cell carcinoma

  2024cites this paper
• Targeting the Ajuba/Notch axis increases the sensitivity of colon cancer cells to 5-fluorouracil

  2024cites this paper
• Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116.

  2024cites this paper
• Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.

  2024cites this paper
• IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer.

  2024cites this paper
• Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors

  2024cites this paper
• Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment

  2024cites this paper
• Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis

  2023cites this paper
• Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma

  2023cites this paper
• Mass Spectrometry-based Metabolomics Approach and in vitro Assays Revealed Promising Role of 2,3-Dihydroquinazolin-4(1H)-one Derivatives Against Colorectal Cancer Cell Lines.

  2023cites this paper
• Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9.

  2023cites this paper
• Update on immune‐based therapy strategies targeting cancer stem cells

  2023cites this paper
• FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells.

  2023cites this paper
• Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance

  2023cites this paper
• Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells.

  2023cites this paper
• Correlation of Plasma Membrane Microviscosity and Cell Stiffness Revealed via Fluorescence-Lifetime Imaging and Atomic Force Microscopy

  2023cites this paper
• Study of insulin-like growth factors and their association with clinic pathological features and survival in colon cancer

  2023cites this paper
• Broad spectrum integrin inhibitor GLPG-0187 bypasses immune evasion in colorectal cancer by TGF-β signaling mediated downregulation of PD-L1.

  2023cites this paper
• Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death

  2023cites this paper
• Clinical Impact of Exosomes in Colorectal Cancer Metastasis.

  2023cites this paper
• Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review

  2023cites this paper
• CLEC5A regulates the proliferation and migration of colon cancer via the AKT/mTOR signaling pathway

  2023cites this paper
• Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models

  2023cites this paper
• Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis

  2023cites this paper
• Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression

  2023cites this paper
• Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia

  2023cites this paper
• A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma

  2023cites this paper
• Redox signaling in drug-tolerant persister cells as an emerging therapeutic target

  2023cites this paper
• Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy

  2023cites this paper
• Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD-L1 and MHC I in colon cancer cells

  2022cites this paper
• The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer

  2022cites this paper
• Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines

  2022cites this paper
• Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine

  2022cites this paper
• Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer

  2022cites this paper
• Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells

  2022cites this paper
• Development of resistance to 5-fluorouracil affects membrane viscosity and lipid composition of cancer cells

  2022cites this paper
• IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis

  2022cites this paper
• Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition

  2022cites this paper
• Functionalized Lineage Tracing Can Enable the Development of Homogenization-Based Therapeutic Strategies in Cancer

  2022cites this paper
• Evidence That β1-Integrin Is Required for the Anti-Viability and Anti-Proliferative Effect of Resveratrol in CRC Cells

  2022cites this paper
• Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.

  2022cites this paper
• Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells.

  2022cites this paper
• Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy

  2022cites this paper
• Single-Cell Image-Based Analysis Reveals Chromatin Changes during the Acquisition of Tamoxifen Drug Resistance

  2022cites this paper
• Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

  2022cites this paper
• Comparison of Colorectal Cancer Stem Cells and Oxaliplatin-Resistant Cells Unveils Functional Similarities

  2022cites this paper
• The paradigm of drug resistance in cancer: an epigenetic perspective

  2022cites this paper
• Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies

  2022cites this paper
• The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer

  2022cites this paper
• The Role of Type 2 Diabetes in Pancreatic Cancer

  2022cites this paper
• Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells

  2022cites this paper
• Polyphyllin VII as a potential drug for targeting stemness in hepatocellular cancer via STAT3 signaling.

  2022cites this paper
• Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance

  2022cites this paper
• Personalized medicine: Stem cells in colorectal cancer treatment.

  2021cites this paper
• Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review

  2021cites this paper
• NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations

  2021cites this paper
• Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer

  2021cites this paper
• Preparation of Mitochondria‐ and Epigenetics‐Targeting Nanoparticles for Suppression of Cancer Metastasis

  2021cites this paper
• αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression

  2021cites this paper
• Genetic and biological hallmarks of colorectal cancer

  2021cites this paper
• Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance

  2021cites this paper
• DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.

  2021cites this paper
• Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers

  2021cites this paper
• Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery.

  2021cites this paper
• RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC

  2021cites this paper
• The Combination of Zerumbone and 5-FU: A Significant Therapeutic Strategy in Sensitizing Colorectal Cancer Cells to Treatment

  2021cites this paper
• OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway

  2021cites this paper
• Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients

  2021cites this paper
• The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma

  2021cites this paper
• Morusin inhibits the growth of human colorectal cancer HCT116-derived sphere-forming cells via the inactivation of Akt pathway

  2021cites this paper
• Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option

  2021cites this paper